|
DE3806565A1
(de)
|
1988-03-01 |
1989-09-14 |
Deutsches Krebsforsch |
Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
|
|
DE3922444A1
(de)
|
1988-03-01 |
1991-01-10 |
Deutsches Krebsforsch |
Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
ES2310580T3
(es)
|
1993-04-30 |
2009-01-16 |
Wellstat Biologics Corporation |
Composiciones purificadas del virus de la enfermedad de newcastle.
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
US5891680A
(en)
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
EP0780475B2
(en)
|
1995-08-09 |
2006-07-19 |
SCHWEIZ. SERUM- & IMPFINSTITUT BERN |
Process for the production of infectious negative-strand RNA viruses
|
|
US6264957B1
(en)
|
1995-09-27 |
2001-07-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
CN1200037A
(zh)
|
1995-10-17 |
1998-11-25 |
韦恩州立大学 |
鸡白细胞介素－15及其用途
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
WO1998013501A2
(en)
|
1996-09-27 |
1998-04-02 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
|
|
DE69842165D1
(de)
|
1997-05-23 |
2011-04-21 |
Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services |
Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
|
|
DE69837764T2
(de)
|
1997-07-11 |
2008-01-31 |
Yale University, New Haven |
Rhabdovirus mit gentechnisch veränderter hülle
|
|
KR20010030630A
(ko)
|
1997-09-19 |
2001-04-16 |
윌리암 에이취 캘넌, 에곤 이 버그 |
약독화 호흡 신시티아 바이러스
|
|
US20030044384A1
(en)
|
1997-10-09 |
2003-03-06 |
Pro-Virus, Inc. |
Treatment of neoplasms with viruses
|
|
EP1905304A3
(en)
|
1997-10-09 |
2008-08-13 |
Wellstat Biologics Corporation |
Treatment of neoplasms with viruses
|
|
US7470426B1
(en)
|
1997-10-09 |
2008-12-30 |
Wellstat Biologics Corporation |
Treatment of neoplasms with viruses
|
|
US7780962B2
(en)
|
1997-10-09 |
2010-08-24 |
Wellstat Biologics Corporation |
Treatment of neoplasms with RNA viruses
|
|
SK288544B6
(sk)
|
1998-06-12 |
2018-03-05 |
Mount Sinai School Of Medicine |
Geneticky skonštruovaný oslabený chimérny vírus chrípky, vakcinačný prostriedok a farmaceutický prostriedok s jeho obsahom a ich použitie
|
|
EP0974660A1
(en)
|
1998-06-19 |
2000-01-26 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Newcastle disease virus infectious clones, vaccines and diagnostic assays
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US7052685B1
(en)
|
1998-10-15 |
2006-05-30 |
Trustees Of The University Of Pennsylvania |
Methods for treatment of cutaneous T-cell lymphoma
|
|
CN1477964A
(zh)
|
1999-04-15 |
2004-02-25 |
|
应用病毒治疗肿瘤
|
|
US20030224017A1
(en)
|
2002-03-06 |
2003-12-04 |
Samal Siba K. |
Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors
|
|
AU4971500A
(en)
|
1999-05-05 |
2000-11-21 |
University Of Maryland |
Production of novel newcastle disease virus strains from cdnas and improved liveattenuated newcastle disease vaccines
|
|
DE122007000070I1
(de)
|
1999-07-14 |
2008-01-31 |
Sinai School Medicine |
In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren
|
|
CA2383276A1
(en)
|
1999-09-24 |
2001-03-29 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
AUPQ425699A0
(en)
*
|
1999-11-25 |
1999-12-23 |
University Of Newcastle Research Associates Limited, The |
A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
|
|
EP1248654B1
(en)
|
2000-01-20 |
2005-10-05 |
Universität Zürich Institut für Medizinische Virologie |
Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
|
|
AU2001257001A1
(en)
|
2000-04-10 |
2001-10-23 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
|
US6818444B2
(en)
|
2000-08-04 |
2004-11-16 |
Heska Corporation |
Canine and feline proteins, nucleic acid molecules and uses thereof
|
|
US7740863B2
(en)
|
2001-04-06 |
2010-06-22 |
Merial |
Recombinant vaccine against West Nile Virus
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
WO2002102404A1
(en)
|
2001-06-18 |
2002-12-27 |
Institut National De La Recherche Agronomique |
Uses of cytokines
|
|
WO2003092579A2
(en)
|
2002-04-29 |
2003-11-13 |
Hadasit Medical Research Services And Development Company Ltd. |
Compositions and methods for treating cancer with an oncolytic viral agent
|
|
CA2488270A1
(en)
|
2002-06-03 |
2003-12-11 |
Dnavec Research Inc. |
Paramyxoviral vectors encoding antibodies, and uses thereof
|
|
AU2003250575A1
(en)
|
2002-08-07 |
2004-02-25 |
Mmagix Technology Limited |
Apparatus, method and system for a synchronicity independent, resource delegating, power and instruction optimizing processor
|
|
SE0203159D0
(sv)
|
2002-10-25 |
2002-10-25 |
Electrolux Ab |
Handtag till ett motordrivet handhållet verktyg
|
|
AU2002953436A0
(en)
|
2002-12-18 |
2003-01-09 |
The University Of Newcastle Research Associates Limited |
A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
|
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
ES2367027T3
(es)
|
2004-02-27 |
2011-10-27 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Sitio de unión de la il-15 para il-15ralfa y mutantes específicos de il-15 que tienen actividad agonista/antagonista.
|
|
CN101027394A
(zh)
|
2004-03-11 |
2007-08-29 |
维若塔歌私人有限公司 |
修饰的溶瘤病毒
|
|
ZA200702269B
(en)
*
|
2004-08-20 |
2008-09-25 |
Viralytics Ltd |
Methods and compositions for treatment of hematologic cancers
|
|
KR101295733B1
(ko)
*
|
2004-08-20 |
2013-08-13 |
비랄리틱스 리미티드 |
혈액암의 치료방법 및 조성물
|
|
KR20070085314A
(ko)
|
2004-11-12 |
2007-08-27 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
재조합 뉴캐슬 질환 바이러스
|
|
CN102166218A
(zh)
|
2005-01-17 |
2011-08-31 |
溶瘤病毒有限公司 |
治疗肿瘤的方法和组合物
|
|
WO2007001677A2
(en)
|
2005-05-17 |
2007-01-04 |
University Of Connecticut |
Compositions and methods for immunomodulation in an organism
|
|
US20090214590A1
(en)
|
2005-07-08 |
2009-08-27 |
Wayne State University |
Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
|
|
CA2825762A1
(en)
*
|
2005-08-31 |
2007-03-08 |
Oncolytics Biotech Inc. |
Method for enhancing anti-neoplastic activity of an oncolytic virus using modified dendritic cells
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
JP5603012B2
(ja)
|
2005-12-02 |
2014-10-08 |
トヘ モウント シナイ スクール オフ メディシネ オフ ニューヨーク ウニベルシトイ |
非天然表面タンパク質を提示するキメラウイルス及びその使用
|
|
EP2366787B1
(en)
|
2006-01-13 |
2019-12-11 |
The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services |
Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells
|
|
WO2007113648A2
(en)
|
2006-04-05 |
2007-10-11 |
Pfizer Products Inc. |
Ctla4 antibody combination therapy
|
|
US20090175826A1
(en)
|
2006-06-05 |
2009-07-09 |
Elankumaran Subbiah |
Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
|
|
CA2658584A1
(en)
|
2006-07-27 |
2008-01-31 |
Ottawa Health Research Institute |
Staged immune-response modulation in oncolytic therapy
|
|
US8765462B2
(en)
|
2007-05-04 |
2014-07-01 |
University Health Network |
IL-12 immunotherapy for cancer
|
|
EP2388266B1
(en)
|
2007-05-11 |
2014-04-23 |
Altor BioScience Corporation |
Fusion molecules and IL-15 variants
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
EP2173378B1
(en)
|
2007-06-27 |
2014-03-19 |
Admune Therapeutics LLC |
Complexes of il-15 and il-15ralpha and uses thereof
|
|
EP2085092A1
(en)
|
2008-01-29 |
2009-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Attenuated oncolytic paramyxoviruses encoding avian cytokines
|
|
EA201500417A1
(ru)
|
2008-08-25 |
2015-11-30 |
Эмплиммьюн, Инк. |
Композиции антагонистов pd-1 и способы применения
|
|
WO2010042433A1
(en)
|
2008-10-06 |
2010-04-15 |
Bristol-Myers Squibb Company |
Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases
|
|
CN101787373B
(zh)
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
EP2393921B1
(en)
|
2009-02-05 |
2015-07-15 |
Icahn School of Medicine at Mount Sinai |
Chimeric newcastle disease viruses and uses thereof
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
US20100297072A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Depinho Ronald A |
Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
|
|
WO2011020047A1
(en)
|
2009-08-14 |
2011-02-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of il-15 to increase thymic output and to treat lymphopenia
|
|
KR101745029B1
(ko)
|
2009-08-21 |
2017-06-08 |
메리얼 인코포레이티드 |
재조합 조류 파라믹소바이러스 백신 및 이의 제조 및 사용 방법
|
|
WO2011041613A2
(en)
|
2009-09-30 |
2011-04-07 |
Memorial Sloan-Kettering Cancer Center |
Combination immunotherapy for the treatment of cancer
|
|
US10238734B2
(en)
|
2010-03-23 |
2019-03-26 |
The Regents Of The University Of California |
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
|
|
WO2012000188A1
(en)
|
2010-06-30 |
2012-01-05 |
Tot Shanghai Rd Center Co., Ltd. |
Recombinant tumor vaccine and method of producing such
|
|
JP6251570B2
(ja)
|
2010-09-21 |
2017-12-20 |
アルター・バイオサイエンス・コーポレーション |
多量体ｉｌ−１５可溶性融合分子並びにその製造及び使用方法
|
|
EP2697368B1
(en)
|
2011-04-15 |
2019-06-05 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
PL3351261T3
(pl)
|
2011-10-11 |
2021-12-06 |
Universität Zürich |
Lek złożony zawierający IL-12 i środek do blokowania cząsteczek hamujących komórki T w terapii nowotworów
|
|
US10238698B2
(en)
|
2012-01-25 |
2019-03-26 |
Dnatrix, Inc. |
Biomarkers and combination therapies using oncolytic virus and immunomodulation
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
US20150250837A1
(en)
|
2012-09-20 |
2015-09-10 |
Morningside Technology Ventures Ltd. |
Oncolytic virus encoding pd-1 binding agents and uses of the same
|
|
US20150359853A1
(en)
|
2012-10-24 |
2015-12-17 |
Admune Therapeutics Llc |
Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
|
|
PE20151921A1
(es)
|
2013-03-14 |
2015-12-26 |
Icahn School Med Mount Sinai |
Virus de la enfermedad de newcastle y usos de los mismos
|
|
JP2016518361A
(ja)
|
2013-04-19 |
2016-06-23 |
シーチューヌ ファルマＣｙｔｕｎｅ Ｐｈａｒｍａ |
血管漏出症候群の発生を抑制するサイトカイン治療
|
|
CA2915397A1
(en)
|
2013-06-17 |
2014-12-24 |
Viralytics Limited |
Methods for the treatment of bladder cancer
|
|
CA2920539C
(en)
|
2013-08-08 |
2024-01-02 |
Cytune Pharma |
Combined pharmaceutical composition
|
|
SI3030575T1
(sl)
|
2013-08-08 |
2018-11-30 |
Cytune Pharma |
Modulokini na osnovi IL-15 in IL-15R-alfa sushi domene
|
|
PL3041490T3
(pl)
|
2013-09-03 |
2019-05-31 |
Medimmune Ltd |
Kompozycje zawierające atenuowany wirus choroby Newcastle i sposoby ich stosowania w leczeniu neoplazji
|
|
AU2015222685A1
(en)
*
|
2014-02-27 |
2016-09-08 |
Viralytics Limited |
Combination method for treatment of cancer
|
|
EP2915569A1
(en)
|
2014-03-03 |
2015-09-09 |
Cytune Pharma |
IL-15/IL-15Ralpha based conjugates purification method
|
|
US10335460B2
(en)
|
2014-07-29 |
2019-07-02 |
Novartis Ag |
IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
MX2017007535A
(es)
|
2014-12-09 |
2017-08-10 |
Merck Sharp & Dohme |
Sistema y metodos para derivar biomarcadores de firmas geneticas de la respuesta a antagonistas de muerte programada 1 (pd-1).
|
|
CN106166294A
(zh)
|
2015-05-18 |
2016-11-30 |
国科丹蓝生物科技（北京）有限公司 |
一种用于术前介入放疗治疗肿瘤的化合物
|
|
US10344067B2
(en)
|
2016-02-25 |
2019-07-09 |
Deutsches Krebsforschungszentrum |
RNA viruses expressing IL-12 for immunovirotherapy
|
|
CN105734023B
(zh)
|
2016-03-28 |
2019-04-26 |
江苏康缘瑞翱生物医药科技有限公司 |
一种重组新城疫病毒在制备抗肝癌药物中的应用
|